MARATTO

article · E3S Web of Conferences

Phytochemical, antioxidant, and anti-inflammatory properties of <i>Tetraclinis articulata</i> (Vahl) Masters extracts from Al Hoceima province

20245 citationsOpen accessAbdelmalek Essaâdi University

Abstract

Tetraclinis articulata (Vahl) Masters (TA), a member of the Cupressaceae family, is frequently used in traditional medicine to treat various health problems in Al Hoceima Province. Our study aimed to determine the content of polyphenols and flavonoids, and to evaluate the biological antioxidant activities using DPPH and FRAP tests. At the same time, we assessed the anti-inflammatory activity of various extracts of TA from Al Hoceima, using the BSA method for each of the extracts studied. The results reveal that ethyl acetate extracts (28.11 mg EAG/g ES), followed by ethanolic extracts (22.42 mg EAG/g ES), show higher quantities than the other extracts. Regarding flavonoids, ethyl acetate extract (90 mg EQ/g ES) and ethanolic extracts (64 mg EQ/g ES) showed the highest concentrations. For antioxidant activity, ethyl acetate and ethanolic extracts showed significant activity, while for anti-inflammatory activity, ethyl acetate and hexanolic extracts showed more marked activity than ethanolic and dichloromethanic extracts. This study reveals that Tetraclinis articulata leaf extracts are an effective antioxidant and natural anti-inflammatory agent. The results indicate the efficacy of TA leafs extracts from the province of Al Hoceima.

Research topics

  • Natural Antidiabetic Agents Studies
  • Phytochemicals and Antioxidant Activities
  • Phytochemistry and Biological Activities

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1051/e3sconf/202452701016

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.